Inventor

Herriot Tabuteau

Inventor

New York, NY, US

Overview

2013–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 244 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes58%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%

C08BPolysaccharides12%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%

C07DHeterocyclic compounds4%

C08LCompositions of macromolecular compounds3%

C07KPeptides2%

C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients0%

Y02ATechnologies for adaptation to climate change0%

PatentTitleYear

11,129,826Bupropion as a modulator of drug activity2021 11,129,895Pharmaceutical compositions comprising meloxicam2021 11,123,344Bupropion as a modulator of drug activity2021 11,123,342Bupropion as a modulator of drug activity2021 11,123,431Pharmaceutical compositions comprising meloxicam2021 11,123,343Bupropion as a modulator of drug activity2021 11,110,173Pharmaceutical compositions comprising meloxicam2021 11,096,937Bupropion as a modulator of drug activity2021 11,090,300Bupropion as a modulator of drug activity2021 11,077,117Pharmaceutical compositions comprising meloxicam2021 11,065,248Bupropion as a modulator of drug activity2021 11,058,648Bupropion as a modulator of drug activity2021 11,045,549Pharmaceutical compositions comprising meloxicam2021 11,020,402Use of reboxetine to treat narcolepsy2021 11,020,483Pharmaceutical compositions comprising meloxicam2021 11,020,389Bupropion as a modulator of drug activity2021 11,013,805Pharmaceutical compositions comprising meloxicam2021 11,013,806Pharmaceutical compositions comprising meloxicam2021 11,007,189Bupropion as a modulator of drug activity2021 10,987,358Pharmaceutical compositions comprising meloxicam2021 10,980,800Bupropion as a modulator of drug activity2021 10,966,941Bupropion as a modulator of drug activity2021 10,966,942Bupropion as a modulator of drug activity2021 10,966,974Bupropion as a modulator of drug activity2021 10,945,973Bupropion as a modulator of drug activity2021 10,940,153Pharmaceutical compositions comprising meloxicam2021 10,940,124Bupropion as a modulator of drug activity2021 10,933,136Pharmaceutical compositions comprising meloxicam2021 10,933,034Bupropion as a modulator of drug activity2021 10,933,137Pharmaceutical compositions comprising meloxicam2021 10,925,842Bupropion as a modulator of drug activity2021 10,918,722Pharmaceutical compositions comprising meloxicam2021 10,905,693Pharmaceutical compositions comprising meloxicam2021 10,898,453Bupropion as a modulator of drug activity2021 10,894,053Pharmaceutical compositions comprising meloxicam2021 10,894,046Bupropion as a modulator of drug activity2021 10,894,047Bupropion as a modulator of drug activity2021 10,881,657Bupropion as a modulator of drug activity2021 10,881,624Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects2021 10,874,664Bupropion as a modulator of drug activity2020 10,874,665Bupropion as a modulator of drug activity2020 10,874,663Bupropion as a modulator of drug activity2020 10,864,209Bupropion as a modulator of drug activity2020 10,821,181Pharmaceutical compositions comprising meloxicam2020 10,821,182Pharmaceutical compositions comprising meloxicam2020 10,813,924Bupropion and dextromethorphan for treating nicotine addiction2020 10,806,710Bupropion as a modulator of drug activity2020 10,799,497Combination of dextromethorphan and bupropion for treating depression2020 10,799,588Pharmaceutical compositions comprising meloxicam2020 10,786,496Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects2020 10,786,469Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects2020 10,780,165Pharmaceutical compositions comprising meloxicam2020 10,780,166Pharmaceutical compositions comprising meloxicam2020 10,780,064Bupropion as a modulator of drug activity2020 10,780,066Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects2020 10,772,850Bupropion as a modulator of drug activity2020 10,758,618Pharmaceutical compositions comprising meloxicam2020 10,758,617Pharmaceutical compositions comprising meloxicam2020 10,729,773Pharmaceutical compositions comprising meloxicam2020 10,729,696Pharmaceutical compositions comprising meloxicam2020 10,729,774Pharmaceutical compositions comprising meloxicam2020 10,729,697Pharmaceutical compositions comprising meloxicam2020 10,722,583Pharmaceutical compositions comprising meloxicam2020 10,702,602Pharmaceutical compositions comprising meloxicam2020 10,702,535Pharmaceutical compositions comprising meloxicam2020 10,695,304Dosage forms and methods for enantiomerically enriched or pure bupropion2020 10,695,429Pharmaceutical compositions comprising meloxicam2020 10,695,430Pharmaceutical compositions comprising meloxicam2020 10,688,185Pharmaceutical compositions comprising meloxicam2020 10,688,066Bupropion and dextromethorphan for treating nicotine addiction2020 10,688,102Combination treatment for migraine and other pain2020 10,653,777Pharmaceutical compositions comprising meloxicam2020 10,596,167Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan2020 10,583,144Pharmaceutical compositions comprising meloxicam2020 10,583,088Pharmaceutical compositions comprising meloxicam2020 10,561,664Pharmaceutical compositions comprising meloxicam2020 10,548,857Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects2020 10,537,642Pharmaceutical compositions comprising meloxicam2020 10,532,101Pharmaceutical compositions comprising meloxicam2020 10,517,950Pharmaceutical compositions comprising meloxicam2019 10,512,692Pharmaceutical compositions comprising meloxicam2019 10,512,693Pharmaceutical compositions comprising meloxicam2019 10,512,643Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects2019 10,493,085Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases2019 10,485,871Pharmaceutical compositions comprising meloxicam2019 10,471,069Pharmaceutical compositions comprising meloxicam2019 10,471,014Pharmaceutical compositions comprising meloxicam2019 10,471,068Pharmaceutical compositions comprising meloxicam2019 10,463,736Pharmaceutical compositions comprising meloxicam2019 10,463,634Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects2019 10,463,682Compositions for oral administration of zoledronic acid or related compounds for treating low back pain2019 10,456,471Pharmaceutical compositions comprising meloxicam2019 10,426,839Pharmaceutical compositions comprising meloxicam2019 10,420,782Dosage forms for oral administration of zoledronic acid or related compounds for treating disease2019 10,413,561Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases2019 10,413,560Dosage forms for oral administration of zoledronic acid or related compounds for treating disease2019 10,369,225Pharmaceutical compositions comprising meloxicam2019 10,369,224Pharmaceutical compositions comprising meloxicam2019 10,363,312Pharmaceutical compositions comprising meloxicam2019 10,350,227Neridronic acid for treating complex regional pain syndrome2019 10,335,424Compositions for oral administration of zoledronic acid or related compounds for treating disease2019 10,322,181Pharmaceutical compositions comprising meloxicam2019 10,307,484Pharmaceutical compositions comprising meloxicam2019 10,265,324Pharmaceutical compositions comprising meloxicam2019 10,265,332Compositions for oral administration of zoledronic acid or related compounds for treating disease2019 10,265,400Pharmaceutical compositions comprising meloxicam2019 10,265,399Pharmaceutical compositions comprising meloxicam2019 10,251,879Bupropion as a modulator of drug activity2019 10,238,672Dosage forms for oral administration of zoledronic acid or related compounds for treating disease2019 10,195,141Dosage forms for oral administration of zoledronic acid or related compounds for treating disease2019 10,195,223Dosage forms for oral administration of zoledronic acid or related compounds for treating disease2019 10,195,278Pharmaceutical compositions comprising meloxicam2019 10,195,279Pharmaceutical compositions comprising meloxicam2019 10,173,986Methods for the safe administration of imidazole or imidazolium compounds2019 10,137,131Pharmaceutical compositions comprising meloxicam2018 10,137,139Dosage forms for oral administration of zoledronic acid or related compounds for treating disease2018 10,117,880Neridronic acid for treating complex regional pain syndrome2018 10,111,894Dosage forms for oral administration of zoledronic acid or related compounds for treating disease2018 10,111,837Dosage forms for oral administration of zoledronic acid or related compounds2018 10,111,891Compositions for oral administration of zoledronic acid or related compounds for treating disease2018 10,105,327Compositions and methods for increasing the metabolic lifetime of dextromethorphane and related pharmacodynamic effects2018 10,105,361Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects2018 10,092,581Osteoclast inhibitors such as zoledronic acid for low back pain treatment2018 10,092,561Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan2018 10,092,560Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects2018 10,080,727Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects2018 10,080,765Neridronic acid for treating complex regional pain syndrome2018 10,064,857Bupropion as a modulator of drug activity2018 10,058,518Bupropion as a modulator of drug activity2018 10,058,614Pharmaceutical compositions comprising meloxicam2018 10,052,338Neridronic acid for treating complex regional pain syndrome2018 10,039,774Neridronic acid for treating complex regional pain syndrome2018 10,039,773Neridronic acid for treating arthritis2018 10,034,890Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome2018 10,028,908Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome2018 10,028,969Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome2018 10,029,010Pharmaceutical compositions comprising meloxicam2018 10,016,445Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome2018 10,016,446Compositions for oral administration of zoledronic acid or related compounds for treating Paget's disease of bone2018 10,004,756Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome2018 9,999,629Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome2018 9,999,628Neridronic acid for treating complex regional pain syndrome2018 9,968,568Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects2018 9,956,238Compositions for administration of zoledronic acid or related compounds for treating low back pain2018 9,956,237Osteoclast inhibitors for knee conditions2018 9,956,234Osteoclast inhibitors for joint conditions2018 9,949,993Compositions for administration of zoledronic acid or related compounds for treating low back pain2018 9,943,531Osteoclast inhibitors such as zoledronic acid for low back pain treatment2018 9,931,352Neridronic acid for treating complex regional pain syndrome2018 9,925,203'Compositions for administration of zoledronic acid or related compounds for treating low back pain'2018 9,920,127'Methods of treating pain with compositions comprising RANK/RANKL antagonists and related compounds'2018 9,901,589'Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome'2018 9,895,383'Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome'2018 9,884,069'Osteoclast inhibitors for knee conditions'2018 9,877,977'Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome'2018 9,867,839'Osteoclast inhibitors for joint conditions'2018 9,867,840'Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome'2018 9,867,819'Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects'2018 9,861,648'Osteoclast inhibitors for knee conditions'2018 9,861,595'Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects'2018 9,855,213'Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome'2018 9,844,559Neridronic acid for treating bone marrow lesions2017 9,827,256Compositions for administration of zoledronic acid or related compounds for treating lower back pain2017 9,827,192Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome2017 9,820,999'Neridronic acid for treating complex regional pain syndrome'2017 9,821,075'Pharmaceutical compositions comprising meloxicam'2017 9,795,622'Neridronic acid for treating pain associated with a joint'2017 9,789,128'Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome'2017 9,782,421'Neridronic acid molecular complex for treating complex regional pain syndrome'2017 9,770,457'Neridronic acid for treating bone marrow lesion'2017 9,763,932'Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects'2017 9,717,747'Osteoclast inhibitors for knee conditions'2017 9,707,247'Compositions for administration of zoledronic acid or related compounds for treating low back pain'2017 9,707,245'Neridronic acid for treating complex regional pain syndrome'2017 9,707,191'Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects'2017 9,700,528'Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects'2017 9,700,570'Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome'2017 9,700,553'Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects'2017 9,694,022'Osteoclast inhibitors for knee conditions'2017 9,688,765'Methods using RANK/RANKL antagonist antibodies for treating pain'2017 9,675,626'Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome'2017 9,669,040'Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome'2017 9,662,343'Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome'2017 9,655,908'Neridronic acid molecular complex for treating complex regional pain syndrome'2017 9,623,038'Osteoclast inhibitors for bone marrow lesions'2017 9,623,037'Osteoclast inhibitors for knee conditions'2017 9,623,036'Osteoclast inhibitors such as zoledronic acid for low back pain treatment'2017 9,616,078'Dosage forms for oral administration of zoledronic acid or related compounds for treating disease'2017 9,616,077'Dosage forms for oral administration of zoledronic acid or related compounds for treating disease'2017 9,610,300'Osteoclast inhibitors for joint conditions'2017 9,585,902'Compositions for oral administration of zoledronic acid or related compounds for treating Paget\'s disease of bone'2017 9,585,901'Dosage forms for oral administration of zoledronic acid or related compounds for treating disease'2017 9,579,323'Compositions comprising RANK/RANKL antagonists and related compounds for treating pain'2017 9,539,268'Therapeutic compositions comprising imidazole and imidazolium compounds'2017 9,522,157'Osteoclast inhibitors for knee conditions'2016 9,517,242'Dosage forms for oral administration of zoledronic acid or related compounds for treating disease'2016 9,511,081'Osteoclast inhibitors for knee conditions'2016 9,493,571'Compositions comprising RANK/RANKL antagonists and related compounds for treating pain'2016 9,486,450'Hydroxybupropion and related compounds as modulators of drug plasma levels'2016 9,474,731'Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects'2016 9,457,025'Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan'2016 9,457,023'Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects'2016 9,427,403'Methods for the safe administration of imidazole or imidazolium compounds'2016 9,421,176'Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects'2016 9,408,861'Osteoclast inhibitors for knee conditions'2016 9,408,815'Bupropion as a modulator of drug activity'2016 9,408,862'Therapeutic compositions comprising imidazole and imidazolium compounds'2016 9,408,860'Compositions for oral administration of zoledronic acid or related compounds for treating low back pain'2016 9,402,843'Compositions and methods of using threohydroxybupropion for therapeutic purposes'2016 9,402,844'Methods of modulating drug plasma levels using erythrohydroxybupropion'2016 9,375,429'Compositions and methods comprising erythrohydroxybupropion and related compounds for improving the efficacy of dextromethorphan'2016 9,370,513'Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects'2016 9,371,392'Treatment of complex regional pain syndrome using denosumab'2016 9,314,462'Compositions and methods for increasing dextromethorphan plasma levels and related pharmacodynamic effects'2016 9,301,964'Dosage forms for oral administration of zoledronic acid or related compounds for treating disease'2016 9,290,575'Compositions comprising RANK/RANKL antagonists and related compounds for treating pain'2016 9,289,441'Osteoclast inhibitors such as zoledronic acid for low back pain treatment'2016 9,289,384'Osteoclast inhibitors for knee conditions'2016 9,289,385'Osteoclast inhibitors for knee conditions'2016 9,283,239'Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome'2016 9,278,095'Bupropion as a modulator of drug activity'2016 9,278,106'Compositions for oral administration of zoledronic acid or related compounds for treating ankylosing spondylitis'2016 9,265,778'Compositions for oral administration of zoledronic acid or related compounds for treating multiple myeloma'2016 9,238,032'Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan'2016 9,216,168'Therapeutic compositions comprising imidazole and imidazolium compounds'2015 9,216,153'Osteoclast inhibitors for knee conditions'2015 9,211,257'Osteoclast inhibitors for knee conditions'2015 9,205,083'Compositions and methods comprising erythrohydroxybupropion and related compounds for improving the efficacy of dextromethorphan'2015 9,205,045'Compositions comprising RANK/RANKL antagonists and related compounds for treating pain'2015 9,198,905'Compositions and methods for reducing dextrorphan plasma levels and related pharmacodynamic effects'2015 9,168,234'Bupropion as a modulator of drug activity'2015 9,149,487'Compositions for oral adminstration of zoledronic acid or related compounds for treating Paget\'s disease of bone'2015 9,127,069'Compositions comprising rank/rankl antagonists and related compounds for treating pain'2015 9,079,927'Substituted imidazolium compounds for treating disease'2015 9,034,889'Compositions for oral administration of zoledronic acid or related compounds for treating low back pain'2015 9,006,279'Substituted imidazolium compounds for treating disease'2015 8,962,599'Therapeutic compositions comprising imidazole and imidazolium compounds'2015 8,901,162'Substituted imidazolium compounds for treating disease'2014 8,901,161'Therapeutic compositions comprising imidazole and imidazolium compounds'2014 8,865,757'Therapeutic compositions comprising imidazole and imidazolium compounds'2014 8,835,650'Substituted imidazolium compounds for treating disease'2014 8,822,436'Compositions for oral administration of zoledronic acid or related compounds for treating disease'2014 8,802,658'Compositions for oral administration of zoledronic acid or related compounds for treating disease'2014 8,569,328'Compositions and methods comprising tilidine or related compounds and dextromethorphan'2013

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2013–2021Patents assigned to ANTECIP BIOVENTURES II LLC (178)· patent assignee history

2013–2021Based in New York, NY, US· patent location history

2014–2021Patents assigned to ANTECIP BIOVENTURES II LLP (4)· patent assignee history

2015Patents assigned to Antecip Bioventures LLC (1)· patent assignee history

2017–2021Patents assigned to AXSOME THERAPEUTICS INC (67)· patent assignee history

2018Patents assigned to ANTECIP BOIVENTURES II LLC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ANTECIP BIOVENTURES II LLC	178	2013–2021
AXSOME THERAPEUTICS INC	67	2017–2021
ANTECIP BIOVENTURES II LLP	4	2014–2021
ANTECIP BOIVENTURES II LLC	1	2018
Antecip Bioventures LLC	1	2015

Locations

Location	Patents	Span
New York, New York, US	244	2013–2021